Article
Mutant prevention concentration, pharmacokinetic-pharmacodynamic integration, and modeling of enrofloxacin data established in diseased buffalo calves.
Journal of veterinary pharmacology and therapeutics - 1 Dec 2015
Ramalingam B, Sidhu P K, Kaur G, Venkatachalam D, Rampal S
Abstract excerpt
The pharmacokinetic-pharmacodynamic (PK/PD) modeling of enrofloxacin data using mutant prevention concentration (MPC) of enrofloxacin was conducted in febrile buffalo calves to optimize dosage regimen and to prevent the emergence of antimicrobial resistance. The serum peak concentration (Cmax ), terminal half-life (t1/2 K10) , apparent volume of distribution (Vd(area) /F), and mean residence time (MRT) of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
